Beyond the Molecule

Beyond the Molecule

From medical school to omni-channel marketing, Megan Dayno’s career has been anything but linear. In this episode of Beyond the Molecule, Megan Dayno shares how her clinical background shapes the way she thinks about HCP journeys, personalization, and innovation in pharma, and why doing omni-channel well is more about better experiences than more channels.

Megan Dayno

Director - Astellas

Key Takeaways

Discover Leadership through Empathy and Alignment

Learn how effective leadership in pharma today is less about authority and more about bringing teams together, understanding diverse perspectives, and creating alignment across functions like medical, commercial, and digital.

Rethink Career Paths as Non-Linear Journeys

Explore how stepping away from a traditional medical path can unlock broader impact. Megan’s journey shows how “detours” often become the foundation for meaningful, large-scale influence.

Put the Customer Journey at the Center of Omnichannel

Understand why true omnichannel is not about more channels, but about designing thoughtful, sequential, and personalized experiences for physicians and patients.

Balance Innovation with Compliance

Gain perspective on how pharma can responsibly embrace AI, personalization, and next-best-action models while staying within the realities of privacy, regulation, and governance.

Learn the Power of Simplicity in Marketing

See why the most underrated skill in modern marketing is simplicity, cutting through noise with relevant, timely, and human messaging that actually resonates.

Embrace Curiosity and Continuous Learning

From AI tools to parenting lessons, discover how curiosity and openness to learning shape better decision-making, stronger teams, and more adaptable leaders.

More Episodes

Partner with us

At the heart of our approach is a commitment to your success. We take time to understand your unique challenges and craft tailored solutions that drive meaningful results. Let’s build something extraordinary together.